Applying Lessons From Cannabis to the Psychedelic Highway-Reference-Cited by-同舟云学术

Applying Lessons From Cannabis to the Psychedelic Highway

Published:2022-06-17 Issue:6 Volume:3 Page:e221618
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Boehnke Kevin F.¹,Davis Alan K.²³,McAfee Jenna¹

Affiliation:

1. Anesthesiology Department, Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor

2. Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus

3. Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland

Publisher

American Medical Association (AMA)

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2793527/boehnke_2022_vp_220014_1655237067.30386.pdf

Reference10 articles.

1. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial.;Davis;JAMA Psychiatry,2021

2. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.;Mitchell;Nat Med,2021

3. Behind schedule—reconciling federal and state marijuana policy.;Haffajee;N Engl J Med,2018

4. Acute illness associated with cannabis use, by route of exposure: an observational study.;Monte;Ann Intern Med,2019

5. How medical are states’ medical cannabis policies?: proposing a standardized scale.;Richard;Int J Drug Policy,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State Cannabis and Psychedelic Legislation and Microdosing Interest in the US;JAMA Health Forum;2024-06-28

2. Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon;Cancers;2024-04-27

3. Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey;Frontiers in Psychiatry;2024-02-22

4. Australian clinical feasibility considerations for treatment of PTSD with cannabinoid-augmented exposure therapy;Australian & New Zealand Journal of Psychiatry;2023-12-07

5. Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study;Journal of Palliative Medicine;2023-12-01